Form 4: Abbott Laboratories EVP and CFO Philip P. Boudreau Reports Changes in Beneficial Ownership

Philip P. Boudreau, EVP and CFO of Abbott Laboratories, reports a disposition of 4,908 common shares to cover tax obligations, leaving a direct holding of 56,553 shares and an indirect holding of 360 shares through a Profit Sharing Trust.

Summary

• On February 28, 2025, Philip P. Boudreau, the EVP and CFO of Abbott Laboratories, reported a change in beneficial ownership of Abbott Laboratories (ABT) common shares.
• The transaction involved the disposition of 4,908 common shares at a price of $135.87.
• This disposition was likely to cover tax obligations related to equity compensation.
• Following the transaction, Boudreau directly owns 56,553 common shares.
• Boudreau also indirectly owns 360 shares through a Profit Sharing Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a routine transaction by a company executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Key Dates